Menu
Back to Journals » OncoTargets and Therapy » Volume 12
Perspectives
Labyrinthin, The Tumor Marker Recognized By MCA 44-3A6: A Case For Pan-Tumor Markers As Targets To Treat Cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,918 | Dovepress* | 4,481+ | 577 | 5,058 | |
| PubMed Central* | 437 | 104 | 541 | ||
| Totals | 4,918 | 681 | 5,599 | ||
| *Since 6 November 2019 | |||||
View citations on PubMed Central and Google Scholar